Differentiation between multiple liver hemangiomas and liver metastases of gastrinomas: Value of enhanced MRI

Journal of Computer Assisted Tomography

Volumn 20, Issue 3, 1996, Pages 349-355

  Berger, Jean François ^a   Laissy, Jean Pierre ^a   Limot, Olivier ^a   Henry Feugeas, Marie Cécile ^a   Cadiot, Guillaume ^a   Mignon, Michel ^a   Schouman Claeys, Elisabeth ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Computed tomography; Gastrinoma; Liver, neoplasms

Indexed keywords

COMPUTERIZED TOMOGRAPHY; LIVER; PATHOLOGY;

COMPUTED TOMOGRAPHY; GASTRINOMA; HAEMANGIOMA; LIVER METASTASIS; LIVER NEOPLASMS; MR SEQUENCE; NEUROENDOCRINE TUMORS; PERIPHERAL ENHANCEMENT; T1-WEIGHTED; T2 WEIGHTED;

TUMORS;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; GASTRINOMA; HUMAN; IMAGE ANALYSIS; LIVER HEMANGIOMA; LIVER METASTASIS; MALE; PRIORITY JOURNAL;

EID: 0029916317     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199605000-00003     Document Type: Article

References (25)

1. Pisegna JR, Doppman JL, Norton JA, Metz DC, Jensen RT. Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome. Dig Dis Sci 1993;7:1318-28.
2. Li KC, Glazer GM, Quint LE, et al. Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging. Radiology 1988;169:409-15.
3. Mignon M, Bonfils S. Diagnosis and treatment of Zollinger-Ellison syndrome. In: Bailliere's Clinical Gastroenterology, vol 2. London: Bailliere Tindall, 1988:677-98.
4. Birnbaum BA, Weinreb JC, Megibow AJ, et al. Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT. Radiology 1990;176:95-101.
5. Lombarde DM, Baker MR, Spritzer CE, Blinder R, Meyers W, Herfkens RJ. Hepatic hemangiomas versus metastases: MR differentiation at 1.5 T. AJR 1990;155:55-9.
6. Ohtomo K, Itai Y, Yoshikawa K, Kokubo T, Iio M. Hepatocellular carcinoma and cavernous hemangioma: differentiation with MR imaging. Radiology 1988;168:621-3.
7. Mirowitz SA, Lee JKT, Heiken JP. Cavernous hemangioma of the liver: assessment of MR tissue specificity with a simplified T2 index. J Comput Assist Tomogr 1990;14:223-8.
8. Glazer GM, Aisen AM, Francis IR, Gyves JW, Lande I, Adler DD. Hepatic cavernous hemangioma: magnetic resonance imaging. Radiology 1985;155:417-20.
9. Ohtomo K, Itai Y, Yoshida H, Kokubo T, Yoshikawa K, Lio M. MR differentiation of hepatocellular carcinoma from cavernous hemangioma. AJR 1989;152:505-7.
10. Egglin TK, Rummeny R, Stark DD, Wittenberg J, Saini D, Ferruci JT. Hepatic tumors: quantitative tissue characterization with MR imaging. Radiology 1990;176:107-10.
11. Hamm B, Thoeni RF, Gould RG, et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994;190:417-23.
12. Itoh K, Saini S, Hahn PF, Imam N, Ferrucci JT. Differentiation between small hepatic hemangiomas and metastases on MR images: importance of size-specific quantitative criteria. AJR 1990;155:61-6.
13. Leslie DF, Johnson CD, Johnson CM, Ilstrup DM, Harmsen WS. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns. AJR 1995;164:625-9.
14. Hamm B, Fischer E, Taupitz M. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging. J Comput Assist Tomogr 1990;14: 205-16.
15. Ferrucci JT. Liver tumor imaging: current concepts. AJR 1990;155:473-84.
16. Semelka RC, Simm EC, Recht M, Deimling M, Lenz G, Laub G. T1-weighted sequences for MR imaging of the liver: comparison of three techniques for single-breath whole-volume acquisition at 1.0 and 1.5 T. Radiology 1991;180: 629-35.
17. Semelka RC, Shoenut JP, Kroeker MA, et al. Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. Radiology 1992;184: 687-94.
18. Yoshida H, Itai Y, Ohtomo K, Kokubo T, Minami M, Yashiro N. Small hepatocellular carcinoma and cavernous hemangioma: differentiation with dynamic FLASH MR imaging with Gd-DTPA. Radiology 1989;171:339-42.
19. Murakami T, Mitani T, Nakamura H, et al. Differentiation between hepatoma and hemangioma with inversion-recovery snapshot FLASH MRI and Gd-DTPA. J Comput Assist Tomogr 1992;16:198-205.
20. Whitney WS, Herfkens RJ, Jeffrey RB, et al. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Radiology 1993; 189:863-70.
21. Yamashita Y, Hatanaka Y, Yamamoto H, et al. Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging. Radiology 1994;193: 59-65.
22. Fechner RE. Benign hepatic lesion and orally administered contraceptives. Hum Pathol 1977;8:225-68.
23. Choi BI, Han MC, Park JM, Kim SM, Han MM, Kim CW. Giant cavernous hemangioma of the liver: CT and MR imaging in 10 cases. AJR 1989;152:1221-6.
24. Mukai K, Grotting JC, Greider M, Rosai J. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Am J Surg Pathol 1982;6:387-99.
25. Creutzfeldt W, Arnold R, Creutzfeldt C, et al. Pathomor-phological, biochemical and diagnosis aspects of gastrinoma. Hum Pathol 1975;6:47-76.